A Pharmacokinetics, Safety and Tolerability Study of Multiple Formulations of BMS-986231 in Healthy Participants
Status:
Completed
Trial end date:
2019-07-29
Target enrollment:
Participant gender:
Summary
Main Objective of this study is to compare the single intravenous (IV) infusion
pharmacokinetics (PK) of BMS-986231 and its metabolites (BMT-284730, BMT-279554, and
CAR-000463) following of up to 2 test formulations of BMS-986231 relative to the reference
formulation.